BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25495942)

  • 1. CXCL16 suppresses liver metastasis of colorectal cancer by promoting TNF-α-induced apoptosis by tumor-associated macrophages.
    Kee JY; Ito A; Hojo S; Hashimoto I; Igarashi Y; Tsuneyama K; Tsukada K; Irimura T; Shibahara N; Takasaki I; Inujima A; Nakayama T; Yoshie O; Sakurai H; Saiki I; Koizumi K
    BMC Cancer; 2014 Dec; 14():949. PubMed ID: 25495942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model.
    Kee JY; Ito A; Hojo S; Hashimoto I; Igarashi Y; Tsukada K; Irimura T; Shibahara N; Nakayama T; Yoshie O; Sakurai H; Saiki I; Koizumi K
    Oncol Rep; 2013 Mar; 29(3):975-82. PubMed ID: 23242131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer.
    Hojo S; Koizumi K; Tsuneyama K; Arita Y; Cui Z; Shinohara K; Minami T; Hashimoto I; Nakayama T; Sakurai H; Takano Y; Yoshie O; Tsukada K; Saiki I
    Cancer Res; 2007 May; 67(10):4725-31. PubMed ID: 17510400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.
    Matsushita K; Toiyama Y; Tanaka K; Saigusa S; Hiro J; Uchida K; Inoue Y; Kusunoki M
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S518-27. PubMed ID: 21845497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
    Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J
    Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis.
    Aslanian AM; Charo IF
    Circulation; 2006 Aug; 114(6):583-90. PubMed ID: 16880330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal Disease.
    Hu ZB; Chen Y; Gong YX; Gao M; Zhang Y; Wang GH; Tang RN; Liu H; Liu BC; Ma KL
    Int J Med Sci; 2016; 13(11):858-867. PubMed ID: 27877078
    [No Abstract]   [Full Text] [Related]  

  • 8. TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation.
    Izquierdo MC; Sanz AB; Mezzano S; Blanco J; Carrasco S; Sanchez-Niño MD; Benito-Martín A; Ruiz-Ortega M; Egido J; Ortiz A
    Kidney Int; 2012 Jun; 81(11):1098-107. PubMed ID: 22278019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine CXCL16 expression suppresses migration and invasiveness and induces apoptosis in breast cancer cells.
    Fang Y; Henderson FC; Yi Q; Lei Q; Li Y; Chen N
    Mediators Inflamm; 2014; 2014():478641. PubMed ID: 24864132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherogenic lipids induce high-density lipoprotein uptake and cholesterol efflux in human macrophages by up-regulating transmembrane chemokine CXCL16 without engaging CXCL16-dependent cell adhesion.
    Barlic J; Zhu W; Murphy PM
    J Immunol; 2009 Jun; 182(12):7928-36. PubMed ID: 19494317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR4 promotes metastasis via ERK/NF-κB/MMP13 pathway and acts downstream of TNF-α in colorectal cancer.
    Ou B; Zhao J; Guan S; Feng H; Wangpu X; Zhu C; Zong Y; Ma J; Sun J; Shen X; Zheng M; Lu A
    Oncotarget; 2016 Jul; 7(30):47637-47649. PubMed ID: 27356745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Inverse signaling" of the transmembrane chemokine CXCL16 contributes to proliferative and anti-apoptotic effects in cultured human meningioma cells.
    Hattermann K; Bartsch K; Gebhardt HH; Mehdorn HM; Synowitz M; Schmitt AD; Mentlein R; Held-Feindt J
    Cell Commun Signal; 2016 Oct; 14(1):26. PubMed ID: 27784296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints.
    van der Voort R; van Lieshout AW; Toonen LW; Slöetjes AW; van den Berg WB; Figdor CG; Radstake TR; Adema GJ
    Arthritis Rheum; 2005 May; 52(5):1381-91. PubMed ID: 15880344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skin.
    Scholz F; Schulte A; Adamski F; Hundhausen C; Mittag J; Schwarz A; Kruse ML; Proksch E; Ludwig A
    J Invest Dermatol; 2007 Jun; 127(6):1444-55. PubMed ID: 17363916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CXCL16 promotes TNF-α-induced apoptosis in DLBCL via the AMAD10-NF-κB regulatory feedback loop.
    Yang H; Qiu B; Chen S; Xun Y; Pan Y; Chen M; Li WX; Liao W; El-Ashram S; Yang A; Liu F
    Cell Biol Int; 2019 Aug; 43(8):863-874. PubMed ID: 31033093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL16 signaling mediated macrophage effects on tumor invasion of papillary thyroid carcinoma.
    Cho SW; Kim YA; Sun HJ; Kim YA; Oh BC; Yi KH; Park DJ; Park YJ
    Endocr Relat Cancer; 2016 Feb; 23(2):113-24. PubMed ID: 26559672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer.
    Ha HK; Lee W; Park HJ; Lee SD; Lee JZ; Chung MK
    Mol Med Rep; 2011; 4(3):419-24. PubMed ID: 21468586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering.
    Singh R; Kapur N; Mir H; Singh N; Lillard JW; Singh S
    Oncotarget; 2016 Feb; 7(6):7343-53. PubMed ID: 26799186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappaB kinetics predetermine TNF-alpha sensitivity of colorectal cancer cells.
    Zwacka RM; Stark L; Dunlop MG
    J Gene Med; 2000; 2(5):334-43. PubMed ID: 11045427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXC chemokine ligand 16, inversely correlated with CD99 expression in Hodgkin Reed-Sternberg cells, is widely expressed in diverse types of lymphomas.
    Liu F; Zhang Y; Tang H; Zhou X; Wu Z; Tang D; Zhao T
    Oncol Rep; 2013 Aug; 30(2):783-92. PubMed ID: 23743627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.